{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:08:17Z","timestamp":1782846497965,"version":"3.54.5"},"reference-count":54,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Benign prostatic hyperplasia (BPH) is highly prevalent among aging men and may lead to progressive lower urinary tract symptoms, surgical intervention, and serious outcomes such as acute urinary retention and renal impairment. In routine clinical practice, the long-term spectrum, timing, and determinants of multiple key outcome events after BPH diagnosis remain insufficiently characterized. This evidence gap is particularly relevant in China, where care pathways, follow-up patterns, and comorbidity profiles may differ from those reported in other populations. A comprehensive real-world description of long-term outcome patterns and determinants is needed to inform risk-stratified follow-up intensity and intervention timing, where current evidence remains limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This study aims to characterize BPH progression trajectories and associated risk factors, quantify long-term risks and time-to-event profiles of major clinical outcomes, and develop and validate prognostic models using multicenter retrospective data from the People\u2019s Liberation Army General Hospital consortium.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We will establish a multicenter retrospective cohort using routinely collected clinical data from the People\u2019s Liberation Army General Hospital consortium (the First, Third, Fourth, Fifth, Sixth, Seventh, and Eighth Medical Centers) spanning 2001 to 2021. The index date is defined as the first recorded BPH diagnosis, and we will include patients with confirmed BPH for whom long-term follow-up data are available. To approximate incident (first-diagnosis) BPH, we applied a 2-year washout period before the index date and cleaned the cohort during assembly by excluding patients with any BPH-related records within this window. Prespecified outcomes include BPH-related surgery, urinary retention, inguinal hernia, chronic kidney disease, urothelial carcinoma, and all-cause mortality. Cox proportional hazard regression will be applied for all-cause mortality, and Fine-Gray competing risk models will be used for nonmortality end points where death may act as a competing event. Model development and validation will be performed across centers, with performance assessed using discrimination, calibration, and clinical utility metrics.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n By mid-January 2026, data collection for the multicenter retrospective dataset (2001\u20102021) had been completed, and data cleaning and harmonization had commenced. As this is a retrospective electronic health record\u2013based study, no participant recruitment is involved; the final analytic sample size will be confirmed after harmonization and cleaning. The baseline characteristic table for cohort 1 (First Medical Center) has been completed as part of data quality control. Completion of data harmonization and the prespecified analyses (including model development and validation) is anticipated by May 2026, followed by dissemination and translation to support routine clinical decision-making.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This protocol describes a large, multicenter, real-world cohort study designed to provide robust long-term evidence on BPH progression and clinically important outcomes in China and establish interpretable and validated prognostic models to inform risk-stratified follow-up and intervention decisions.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/84965","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:30:06Z","timestamp":1769628606000},"page":"e84965-e84965","source":"Crossref","is-referenced-by-count":0,"title":["Disease Progression and Outcomes in Patients With Benign Prostatic Hyperplasia: Protocol for a Multicenter Retrospective Cohort Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6081-3777","authenticated-orcid":false,"given":"Zexuan","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2540-6804","authenticated-orcid":false,"given":"Jiaxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9231-4235","authenticated-orcid":false,"given":"Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0608-6509","authenticated-orcid":false,"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5513-5671","authenticated-orcid":false,"given":"Fan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4404-3467","authenticated-orcid":false,"given":"Bingyang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6759-8160","authenticated-orcid":false,"given":"Hongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7828-5933","authenticated-orcid":false,"given":"Hongzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8615-2029","authenticated-orcid":false,"given":"Chao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"5","key":"R1","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00120-024-02327-1","article-title":"Case-based presentation of the S2e guideline on the diagnosis and treatment of benign prostatic hyperplasia","volume":"63","author":"Bschleipfer","journal-title":"Urologie"},{"issue":"1","key":"R2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/CU9.0000000000000257","article-title":"Holmium laser enucleation of the prostate versus transurethral resection of the prostate in treatment of benign prostatic hyperplasia: a meta-analysis of 13 randomized control trials","volume":"19","author":"Daryanto","journal-title":"Curr Urol"},{"issue":"5","key":"R3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/pros.24656","article-title":"Link between circadian rhythm and benign prostatic hyperplasia (BPH)\/lower urinary tract symptoms (LUTS)","volume":"84","author":"Cavanaugh","journal-title":"Prostate"},{"issue":"3","key":"R4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1024\/0040-5930\/a001423","article-title":"Benign prostate hyperplasia - current medical therapy, new developments, and side effects","volume":"80","author":"Tamalunas","journal-title":"Ther Umsch"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.3389\/fruro.2024.1446650","article-title":"Giant prostatic hyperplasia in a 54-years old patient treated by prostate artery embolization: case report","volume":"4","author":"Villard","journal-title":"Front Urol"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"14801","DOI":"10.1038\/s41598-023-41781-3","article-title":"Diagnostic efficacy of systemic immune-inflammation biomarkers in benign prostatic hyperplasia using receiver operating characteristic and artificial neural network","volume":"13","author":"Ahmed","journal-title":"Sci Rep"},{"issue":"14","key":"R7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411634","article-title":"Mechanism of androgen-independent stromal proliferation in benign prostatic hyperplasia","volume":"24","author":"Hata","journal-title":"Int J Mol Sci"},{"issue":"14","key":"R8","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1080\/14656566.2023.2237406","article-title":"Overview of current pharmacotherapeutic options in benign prostatic hyperplasia","volume":"24","author":"Koudonas","journal-title":"Expert Opin Pharmacother"},{"issue":"12","key":"R9","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1007\/s11010-023-04695-2","article-title":"Comparative RNA-sequencing analysis of the prostate in a mouse model of benign prostatic hyperplasia with bladder outlet obstruction","volume":"478","author":"Tang","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"R10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/path.6074","article-title":"Steroid hormone imbalance drives macrophage infiltration and Spp1\/osteopontin foam cell differentiation in the prostate","volume":"260","author":"Popovics","journal-title":"J Pathol"},{"issue":"4","key":"R11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/03915603231189627","article-title":"The effect of acute urinary retention on the results of transurethral resection of the prostate","volume":"90","author":"Baran","journal-title":"Urologia"},{"issue":"3","key":"R12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030674","article-title":"Additive value of pyridostigmine to silodosin in the management of acute urinary retention secondary to benign prostatic hyperplasia: a randomized controlled trial","volume":"14","author":"Mohamed","journal-title":"J Clin Med"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123799","article-title":"A novel approach to bladder dysfunction induced by bladder outlet obstruction: Low-intensity extracorporeal shock wave therapy promotes bladder regeneration","volume":"378","author":"Wu","journal-title":"Life Sci"},{"issue":"9","key":"R14","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jama.2025.7045","article-title":"Lower urinary tract symptoms in men: a review","volume":"334","author":"Wei","journal-title":"JAMA"},{"issue":"4","key":"R15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11306-025-02290-8","article-title":"Self-organizing maps to aid prognostic and diagnostic biomarker identification in exploratory metabolomics of benign prostatic hyperplasia","volume":"21","author":"Camelo","journal-title":"Metabolomics (Los Angel)"},{"issue":"6","key":"R16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/CU9.0000000000000299","article-title":"Tackling the progression of benign prostatic hyperplasia\/benign prostatic obstruction progression: deobstructing within the \u201cwindow of curability\u201d (a hypothesis-generating review)","volume":"19","author":"Kuang","journal-title":"Curr Urol"},{"issue":"1","key":"R17","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-024-01240-6","article-title":"AI for BPH surgical decision-making: cost effectiveness and outcomes","volume":"26","author":"Lama","journal-title":"Curr Urol Rep"},{"issue":"1","key":"R18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023","volume":"211","author":"Sandhu","journal-title":"J Urol"},{"issue":"11","key":"R19","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00270-024-03802-0","article-title":"Two-year outcomes of prostatic artery embolization for symptomatic benign prostatic hyperplasia: an international, multicenter, prospective study","volume":"47","author":"Sapoval","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"10","key":"R20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72223","article-title":"Retrospective assessment of post-transurethral resection of the prostate complications in benign prostatic hyperplasia patients: impact of acute urinary retention","volume":"16","author":"Ahmed","journal-title":"Cureus"},{"issue":"2","key":"R21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1089\/acu.2023.0081","article-title":"Electroacupuncture therapy for urinary retention in an elderly patient","volume":"36","author":"Khasanah","journal-title":"Med Acupunct"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5534\/wjmh.240306","article-title":"Development of a new diagnostic tool (LUTS\/BPH Score) for male lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"44","author":"Jeh","journal-title":"World J Mens Health"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123192","article-title":"Association between metabolic syndrome and benign prostatic hyperplasia: the underlying molecular connection","volume":"358","author":"Fu","journal-title":"Life Sci"},{"issue":"5","key":"R24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11934-024-01199-4","article-title":"Medical advancements in benign prostatic hyperplasia treatments","volume":"25","author":"Ganesan","journal-title":"Curr Urol Rep"},{"issue":"2","key":"R25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/bju.16304","article-title":"Systematic review and network meta-analysis of re-intervention rates of new surgical interventions for benign prostatic hyperplasia","volume":"134","author":"Shin","journal-title":"BJU Int"},{"issue":"4","key":"R26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ucl.2025.08.001","article-title":"Medical therapy for benign prostatic hyperplasia and lower urinary tract symptoms","volume":"52","author":"Te","journal-title":"Urol Clin North Am"},{"issue":"6","key":"R27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.diii.2023.01.012","article-title":"Long-term outcomes of prostate artery embolization for acute urinary retention: an analysis of 88 patients","volume":"104","author":"Marchi","journal-title":"Diagn Interv Imaging"},{"issue":"1","key":"R28","doi-asserted-by":"publisher","first-page":"31556","DOI":"10.1038\/s41598-024-83483-4","article-title":"Magnitude and factors associated with benign prostatic hyperplasia among adult male patients visiting Wolaita Sodo University comprehensive specialized hospital southern Ethiopia","volume":"14","author":"Tiruneh","journal-title":"Sci Rep"},{"issue":"3","key":"R29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41391-023-00731-w","article-title":"Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression","volume":"27","author":"Gravas","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"R30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.50980","article-title":"Elements for trial without catheter (TWOC) success in benign prostatic hyperplasia patients: lessons we have learned","volume":"15","author":"Ivanuta","journal-title":"Cureus"},{"issue":"4","key":"R31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.eururo.2024.04.031","article-title":"Bladder outlet obstruction relief and symptom improvement following medical and surgical therapies for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review","volume":"86","author":"Creta","journal-title":"Eur Urol"},{"issue":"7","key":"R32","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s11255-024-04355-4","article-title":"The predictive value of prostate spherical volume ratio in lower urinary tract symptoms and clinical progression of benign prostatic hyperplasia: a retrospective cohort study","volume":"57","author":"Ji","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","first-page":"2478875","DOI":"10.1080\/13685538.2025.2478875","article-title":"National prevalence and incidence of benign prostatic hyperplasia\/lower urinary tract symptoms and validated risk factors pattern","volume":"28","author":"Lin","journal-title":"Aging Male"},{"issue":"10","key":"R34","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s00120-023-02183-5","article-title":"Conservative and pharmacological treatment of benign prostatic hyperplasia: the German S2e-guideline 2023-part2","volume":"62","author":"Bschleipfer","journal-title":"Urologie"},{"issue":"8","key":"R35","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/nau.25530","article-title":"The urinary and prostatic microbiome in non-neurogenic male LUTS\/BPH: a systematic review","volume":"43","author":"Pina-Vaz","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"R36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12875-024-02378-5","article-title":"Life disturbance and hospital visit experiences among Chinese patients with benign prostatic hyperplasia: a qualitative study","volume":"25","author":"An","journal-title":"BMC Prim Care"},{"issue":"12","key":"R37","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1007\/s00345-023-04658-8","article-title":"Benign prostatic hyperplasia burden comparison between China and United States based on the global burden of disease study 2019","volume":"41","author":"Liu","journal-title":"World J Urol"},{"issue":"2","key":"R38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2307\/2531021","volume":"39","author":"Schoenfeld","journal-title":"Biometrics"},{"issue":"12","key":"R39","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates","volume":"48","author":"Peduzzi","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"R40","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes","volume":"38","author":"Riley","journal-title":"Stat Med"},{"issue":"11","key":"R41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.34427","article-title":"Assessment of frailty and association with progression of benign prostatic hyperplasia symptoms and serious adverse events among men using drug therapy","volume":"4","author":"Bauer","journal-title":"JAMA Netw Open"},{"issue":"3","key":"R42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1590\/S1677-5538.IBJU.2024.0039","article-title":"Long-term functional outcomes and surgical retreatment after thulium laser enucleation of the prostate: a 10-year follow-up study","volume":"50","author":"Manfredi","journal-title":"Int Braz J Urol"},{"issue":"8","key":"R43","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67027","article-title":"The assessment of patient-reported outcomes in the medical management of patients with benign prostatic hyperplasia","volume":"16","author":"Adil Mehmood","journal-title":"Cureus"},{"issue":"9","key":"R44","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18083","article-title":"Rezum therapy for benign prostatic hyperplasia: Dubai\u2019s initial experience","volume":"13","author":"Rowaiee","journal-title":"Cureus"},{"key":"R45","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S414799","article-title":"Procedural intervention for benign prostatic hyperplasia in men \u2265 age 70 years - a review of published literature","volume":"18","author":"Codelia-Anjum","journal-title":"Clin Interv Aging"},{"issue":"1","key":"R46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06628-8","article-title":"The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"7","author":"Lee","journal-title":"Sci Rep"},{"issue":"5","key":"R47","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.mayocp.2024.11.024","article-title":"Benign prostatic hyperplasia increases long-term chronic kidney disease risk","volume":"100","author":"Ouyang","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"R48","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.cgh.2024.05.043","article-title":"The revised Kyoto criteria and risk of malignancy among patients with intraductal papillary mucinous neoplasms","volume":"22","author":"Hamada","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"R49","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.cgh.2023.01.032","article-title":"Clinical outcomes of intraductal papillary mucinous neoplasms with dilatation of the main pancreatic duct","volume":"21","author":"Hamada","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"R50","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-00989-9","article-title":"Clinical efficacy and complications of transurethral resection of the prostate versus plasmakinetic enucleation of the prostate","volume":"28","author":"Yang","journal-title":"Eur J Med Res"},{"key":"R51","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18615","article-title":"Comparative efficacy and safety of 180 W XPS . 120 W HPS GreenLight laser therapy for benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"12","author":"Wang","journal-title":"PeerJ"},{"issue":"2","key":"R52","doi-asserted-by":"publisher","first-page":"144","DOI":"10.22037\/uj.v16i7.5866","article-title":"Association between 5-alpha reductase inhibitor use and the risk of depression: a meta-analysis","volume":"18","author":"Deng","journal-title":"Urol J"},{"issue":"3","key":"R53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265060","article-title":"Association between benign prostatic hyperplasia and suicide in South Korea: a nationwide retrospective cohort study","volume":"17","author":"Lee","journal-title":"PLoS ONE"},{"issue":"2","key":"R54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.prnil.2017.12.003","article-title":"The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia","volume":"6","author":"Cakir","journal-title":"Prostate Int"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e84965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:19:04Z","timestamp":1782843544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e84965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":54,"URL":"https:\/\/doi.org\/10.2196\/84965","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"article-number":"v15i5e84965"}}